top of page
color cloud.png
James Rucker
no pic.jpg
no pic.jpg

James Rucker

King's College London
UK

James Rucker is a Clinician Scientist Fellow funded by the UK National Institute for Health Research in mood disorders at The Institute of Psychiatry, Psychology & Neuroscience, King’s College London and Honorary Consultant Psychiatrist at the South London and Maudsley NHS Foundation Trust. Dr Rucker completed his medical degree at University College London (UK) in 2003 before training in psychiatry at the Maudsley, Bethlem and Springfield Hospitals in South London. He completed his PhD in the molecular biology of mood disorders at King’s College London in 2012 under Emeritus Professor Peter McGuffin. Dr Rucker specialises clinically and academically in mental health problems predominantly associated with mood, anxiety and trauma response symptoms and is particularly interested in novel drug treatments and drug catalysed forms of psychotherapy in the same. He leads the Psychedelic Trials Group at King’s College London, with Professor Allan Young. Clinically, he works at a specialist treatment centre for mood disorders at The Maudsley. He is also a Consultant Psychiatrist for Sapphire Medical Clinics, the first Medical Cannabis Clinic in the UK to be approved by the Care Quality Commission.

color cloud.png

Stay Up to Date

Never miss a deadline. Get the latest to your inbox. 

Thanks for subscribing!

About Psychedelic Medicine – Israel 2024

With the rediscovery of psychedelic drugs as potential treatments for psychiatric disorders, we may be on the verge of the next revolution. The potential impact of psychedelics is not limited to psychiatry. Fields such as neurology, palliative care, addiction and pain medicine are among the potential beneficiaries along with inflammatory and possibly autoimmune disorders. 

Conference Organizer
Screen Shot 2022-10-23 at 20.47.10.png

© Target Conferences 2022, All rights reserved.

Terms And Conditions

Privacy Policy

bottom of page